Newsroom | 4601 results

LOS ANGELES--(BUSINESS WIRE)--It’s no secret that our waistlines often expand in middle-age, but the problem isn’t strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing our risk for developing diabetes, heart problems and other chronic diseases. Exactly how age transforms a six pack into a softer stomach, however, is murky. Now preclinical research by City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United Stat...

PHOENIX--(BUSINESS WIRE)--The Steele Foundation held a private ribbon-cutting ceremony for the new Daniel Cracchiolo Institute for Pediatric Autoimmune Disease Research....

METAIRIE, La.--(BUSINESS WIRE)--RestorixHealth, the nation’s leading wound care solutions company, has announced new corporate leadership in Ben Dunford, MBA, as Chief Executive Officer (CEO) and Melinda Estep, MBA, as Chief Financial Officer (CFO). Dunford brings to RestorixHealth a wealth of healthcare experience serving in various c-suite roles, including CFO at Texas Regional Medical Center at Sunnyvale, Chief Operating Officer (COO) at NorthStar Anesthesia, President of Rural Physicians Gr...

PITTSBURGH--(BUSINESS WIRE)--Collagen is well-known as an important component of skin, but its impact is much greater, as it is the most abundant protein in the body, providing structure and support to nearly all tissues and organs. Using their novel Freeform Reversible Embedding of Suspended Hydrogels (FRESH) 3D bioprinting technique, which allows for the printing of soft living cells and tissues, Carnegie Mellon’s Feinberg lab has built a first-of-its-kind microphysiologic system, or tissue m...

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc announces that it was Certified™ by Great Place to Work® for the fourth year in a row....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, an investigational, once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), today announced it will present immunogenicity and biomarker analyses from its Phase 2 study, in participants with stage F2 and F3 fibrosis due to MASH. The results will be presented in a state-of-the-art lecture and poster at Digestive Dise...

BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health announce the application of AI and machine learning technologies to identify high-risk patient groups that may benefit the most from interventions that preserve lean muscle mass during GLP-1 treatment for diabetes, weight loss, and chronic weight management....

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, Image and Likeness program exclusively for college athletes with diabetes – for an expanded fourth season, including the first-ever nationwide open call for passionate and inspiring college athletes to join its roster. Now through May 23, athletes, coaches, friends and family members can nominate candidates through an online submissio...

SAN DIEGO--(BUSINESS WIRE)--Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health...

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a provider of chronic disease management software, is proud to announce that it has successfully attained SOC 2 Type II certification. This certification, awarded by the American Institute of Certified Public Accountants (AICPA), is a rigorous audit that evaluates a company's controls relevant to security, availability, processing integrity, confidentiality, and privacy. Dr. Doug Romer, CMO, stated, “this milestone underscores MedsEngine’s continued co...